Ipilimumab-Induced Enteritis without Colitis: A New Challenge

by Marcus Messmer, Sunita Upreti, Yaman Tarabishy, Nikhilesh Mazumder, Reezwana Chowdhury, Mark Yarchoan, Matthias Holdhoff
Published 2016-11-01

Hemophagocytic Lymphohistiocytosis Secondary to PD-1 and IDO Inhibition in a Patient with Refractory Glioblastoma

by Rohit Thummalapalli, Thatcher Heumann, Julie Stein, Sarah Khan, David S. Priemer, Amy S. Duffield, John Laterra, Rima Couzi, Michael Lim, Matthias Holdhoff
Published 2020-05-01

Widely metastatic IDH1-mutant glioblastoma with oligodendroglial features and atypical molecular findings: a case report and review of current challenges in molecular diagnostics

by Carlos G. Romo, Doreen N. Palsgrove, Ananyaa Sivakumar, Christen R. Elledge, Lawrence R. Kleinberg, Kaisorn L. Chaichana, Christopher D. Gocke, Fausto J. Rodriguez, Matthias Holdhoff
Published 2019-02-01

788 Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety and cerebrospinal fluid biomarkers

by Chen Hu, Jarushka Naidoo, Wei Fu, Patrick Forde, Julie Brahmer, Evan Lipson, Joanne Riemer, Stuart Grossman, Chetan Bettegowda, Roisin Connolly, Cesar Santa-Maria, Karisa Schreck, Matthias Holdhoff, Amanda Barnes, Nafi Aygun, Lawrence Kleinberg, Kristin Redmond, Christopher Douville, Arun Venkatesan
Published 2020-11-01

Re-irradiation for malignant glioma: Toward patient selection and defining treatment parameters for salvage

by Colette J. Shen, MD, PhD, Megan N. Kummerlowe, BS, Kristin J. Redmond, MD, MPH, Juan Carlos Martinez-Gutierrez, MD, Syed Muhammad Usama, MBBS, Matthias Holdhoff, MD, PhD, Stuart A. Grossman, MD, John J. Laterra, MD, PhD, Roy E. Strowd, MD, Lawrence R. Kleinberg, MD
Published 2018-10-01